Valeo Medical Inc.
This article was originally published in Start Up
Executive Summary
The founders of Valeo Medical believe that endometriosis, a leading cause of infertility in the US, is a type of auto-immune disorder. Based on this premise, Valeo is developing an endometriosis diagnostic by searching for auto-antibodies to a variety of carbohydrate antigens in serum samples. The company believes the market opportunity is great, because there is no non-invasive diagnostic for endometriosis.
You may also be interested in...
Women's Health: A Growing Market for Diagnostic Players
Women's health is an area long shunned by pharmaceutical and diagnostic companies. But that is starting to change thanks to the successes of companies such as Cytyc and Digene, who have built successful testing franchises in the Ob/ Gyn market. As companies such as PerkinElmer and others look to develop new tests in this market, a spate of start-ups are developing technologies that might fit the bill. Of greatest interest are the so-called molecular tests since they offer the advantage of premium pricing.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.